Myriad GeneticsMYGN 
$28.47-0.45%24h
-0.45%24h
Global rank4435
Market cap$2.55B
Change 7d2.15%
YTD Performance50.79%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Myriad Genetics (MYGN)
As of November 2024, Myriad Genetics has a market cap of $2.55B. This makes Myriad Genetics the world's 4435th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Myriad Genetics from 1995 to 2024
-
Value:-
Market cap history of Myriad Genetics from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $2.10B | 22.26% |
| 2023 | $1.72B | 31.91% |
| 2022 | $1.30B | -47.43% |
| 2021 | $2.47B | 39.61% |
| 2020 | $1.77B | -27.40% |
| 2019 | $2.44B | -6.33% |
| 2018 | $2.61B | -15.37% |
| 2017 | $3.08B | 106.06% |
| 2016 | $1.49B | -61.38% |
| 2015 | $3.87B | 26.72% |
| 2014 | $3.05B | 62.35% |
| 2013 | $1.88B | -23.01% |
| 2012 | $2.44B | 30.13% |
| 2011 | $1.88B | -8.32% |
| 2010 | $2.05B | -12.46% |
| 2009 | $2.34B | -21.25% |
| 2008 | $2.97B | 42.74% |
| 2007 | $2.08B | 48.31% |
| 2006 | $1.40B | 50.48% |
| 2005 | $932.25M | -7.60% |
| 2004 | $1.01B | 75.04% |
| 2003 | $576.38M | -11.92% |
| 2002 | $654.37M | -72.26% |
| 2001 | $2.36B | -36.39% |
| 2000 | $3.71B | 259.78% |
| 1999 | $1.03B | 360.00% |
| 1998 | $224.10M | -58.76% |
| 1997 | $543.44M | -3.96% |
| 1996 | $565.85M | -22.61% |
| 1995 | $731.12M | - |
MYGN Market Cap Today is $2.55B -0.45% - 4 Nov 2024
View largest stocks by market cap 
